Discuss the therapeutic rationale for guideline-directed medical therapy (GDMT) for patients with chronic kidney disease (CKD) or heart failure (HF), with concomitant hyperkalemia (HK) Recognize the risk of HK in patients receiving chronic therapy for HF or CKD Apply clinical pathways or algorithms for cross-specialty collaboration in management of patients with HK Explain the rationale for chronic HK management in patients with HF or CKD using concomitant therapies, including renin angiotensin aldosterone inhibitors (RAASis) and potassium binders
- Provider:Global Learning Collaborative
- Activity Link: https://reachmd.com/programs/26746
- Start Date: 2024-12-20 06:00:00
- End Date: 2024-12-20 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest